05:16 PM EST, 12/31/2024 (MT Newswires) -- Alan J Russell, Director, Chief Scientific Officer, on December 30, 2024, sold 100,000 shares in Edgewise Therapeutics ( EWTX ) for $2,737,470. Following the Form 4 filing with the SEC, Russell has control over a total of 14,863 shares of the company, with 14,863 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1710072/000156218024008663/xslF345X05/primarydocument.xml